2: Immunopharmacology, Relations, and General Problems
نام نخستين پديدآور
edited by Georges Mathé, Franco M. Muggia.
وضعیت نشر و پخش و غیره
محل نشرو پخش و غیره
Berlin, Heidelberg
نام ناشر، پخش کننده و غيره
Springer Berlin Heidelberg
تاریخ نشرو بخش و غیره
1980
مشخصات ظاهری
نام خاص و کميت اثر
(xi, 259 pages 76 illustrations)
فروست
عنوان فروست
Recent Results in Cancer Research, Fortschritte der Krebsforschung / Progrès dans les recherches sur le cancer, 75.
یادداشتهای مربوط به مندرجات
متن يادداشت
Tumor-Specific Antigens --;Autoreactive Cells as Mediators of the Natural Defense Against Malignant Tumors --;Progress in Experimental Systemic Active Immunotherapy of Cancer --;Host's Immune State and Kinetics of Local Tumor Growth Control --;Progression of Postoperative Lung Metastasis --;Immunotherapy Versus Chemotherapy of Acute Myeloid Leukemia: Response to PHA, Allogeneic Lymphocytes, and Leukemic Myeloblasts of Remission Lymphocytes from Leukemia Patients --;Suppressor Cells in Hodgkin's Disease and Lung Carcinoma --;Immune Imbalance in Cancer Patients --;Immunorestoration of Anergic Cancer Patients by Azimexon --;BCG Versus VCN: The Antigenicity and the Adjuvant Effect of Both Compounds --;Differences in Chemotherapeutic Susceptibility of Human T-, B-, and Non-T-/Non-B-Lymphocytes in Culture --;The Significance of Lectin Receptors in the Kidney and in Hypernephroma (Renal Adenocarcinoma) --;Specific Immunotherapy of Acute Lymphoid Leukemia Patients by REH Cell Line --;Results of Postoperative Treatment of Colorectal Cancer by Radiotherapy, Chemotherapy and Immunotherapy --;Some 'Pharmacologic' Data About Corynebacterium Parvum --;Increased Resistance to Tumor Graft in Mice Infected by Vaccinal Strains of Brucella Abortus --;Thymosin: Basic Properties and Clinical Application in the Treatment of Immunodeficiency Diseases and Cancer --;One or Several Thymic Hormones? --;Ability of Thymosin to Decrease in Vivo and in Vitro Suppressor Cell Activity in Tumor Bearing Mice and Cancer Patients --;Screening of Small Molecular Microbial Products Modulating Immune Responses and Bestatin --;A Review of Clinical Studies of Bestatin --;Bestatin Treatment and the Peripheral Lymphocyte Population in Cancer Patients --;Correction of Immunodeficiency in Aged Mice by Levamisole and Bestatin Administration --;Therapeutic Effects of BM 12,531 (Prop. INN Azimexon) --;In Vivo Immunomodulating Properties of Two Synthetic Agents: Azimexon and Tuftsin --;Effects of BM 12,531 (Azimexon) on in Vitro Lymphocyte and Macrophage Proliferation --;Comparative Evaluation of the Tumor Inhibitory and Antibacterial Activity of Solubilized and Particulate Glucan --;Mechanism of the Inhibitory Effect of Levan on Experimental Tumors --;Lynestrenol: A Progesterone like Agent with Immunostimulatory Properties --;Chemotherapy Immunogenicity --;Selective Imbalances of Cellular Immune Responses by Adriamycin --;The Heterogeneity of the Interaction Between Cancer Chemotherapeutic Agents and Host Resistance Mechanisms --;Endotoxin-Induced Tumor Necrosis Factor --;Antimicrobial Resistance Enhancing Activity of Tumor Necrosis Serum Factor Induced by Endotoxin in BCG-TreatedMice --;Tumor-Necrotizing Serum Production by Administration of BCG + Pseudomonas: Its Application in Treatment of Fibrosarcoma in Mice --;Usefulness of the Results of Studies on the Antitumor Effects of Interferon in Animals to Interferon-Therapy of Patients --;DNA, Liposomes, and Proteins as Carriers for Antitumoral Drugs --;Antibodies as Carriers for Oncostatic Materials --;Pulmonary Localization of Intravenously Injected Liposomes --;Erythrocytes and Lymphocytes as Drug Carrier Systems: Techniques for Entrapment of Drugs in Living Cells --;Chemo- and Immunopharmacology: The Reality and the Horizons of Cancer Treatment.
موضوع (اسم عام یاعبارت اسمی عام)
موضوع مستند نشده
Medicine.
موضوع مستند نشده
Pharmacy.
موضوع مستند نشده
Toxicology.
نام شخص به منزله سر شناسه - (مسئولیت معنوی درجه اول )